# Oasys vs. Extreme H20 Xtra 59

> **NCT00477763** · PHASE4 · COMPLETED · sponsor: **Innovative Medical** · enrollment: 52 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Restasis, Refresh Endura

## Key facts

- **NCT ID:** NCT00477763
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2008-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477763, "Oasys vs. Extreme H20 Xtra 59". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00477763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*